Dataset Information

Buyers' role in innovation procurement: Evidence from US military R&D contracts.

ABSTRACT: This study provides the first quantification of buyers' role in the outcome of R&D procurement contracts. We combine together four data sources on US federal R&D contracts, follow-on patented inventions, federal public workforce characteristics, and perception of their work environment. By exploiting the observability of deaths of federal employees, we find that managers' death events negatively affect innovation outcomes: a 1% increase in the share of relevant public officer deaths causes a decline of 32.3% of patents per contract, 20.5% patent citations per contract, and 34.3% patent claims per contract. These effects are driven by the deaths occurring in the 6 months before the contract is awarded, thereby indicating the relevance of the design and award stage relative to ex post contract monitoring. Lower levels of self-reported within-office cooperation also negatively impact R&D outcomes.

SUBMITTER: Decarolis F

PROVIDER: S-EPMC8597003 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Buyers' role in innovation procurement: Evidence from US military R&D contracts.

Decarolis Francesco F de Rassenfosse Gaétan G Giuffrida Leonardo M LM Iossa Elisabetta E Mollisi Vincenzo V Raiteri Emilio E Spagnolo Giancarlo G

Journal of economics & management strategy 20210620 4

This study provides the first quantification of buyers' role in the outcome of R&D procurement contracts. We combine together four data sources on US federal R&D contracts, follow-on patented inventions, federal public workforce characteristics, and perception of their work environment. By exploiting the observability of deaths of federal employees, we find that managers' death events negatively affect innovation outcomes: a 1% increase in the share of relevant public officer deaths causes a dec ...[more]

PMID: 34819715

Similar Datasets

Project description:Small and Medium Scale Enterprises (SMEs) are known to drive innovations, economic growth, and job creation. Numerous studies have analysed small businesses' innovations using new products and processes, with indicators such as funding, innovation activities, and collaborations. However, other vital determinants such as public procurement contracts and intellectual property rights protections capable of influencing innovations have not received enough scholarly attention, especially in the context of Central European countries. This paper aims to examine whether public procurement contracts, market orientations, public subsidies, intellectual property rights, and other firm characteristics shape small businesses' innovation outcomes in the Czech Republic. The results based on a cross-sectional sample of 4,193 small businesses from the Community Innovation survey 2014 prove that European utility models positively influence major and minor forms of innovation but not general innovations. Our findings also show that foreign procurement contracts matter for small businesses' major and minor forms of innovation but not general innovations. Our results further demonstrate that exporting, collaborations with universities and other public research organizations, and external research and development positively influence major and minor forms of innovation but not general innovations. The results on the average treatment effects confirm that firms' collaborations with universities and public research organizations have the highest additionality effects on major and minor forms of innovations. Finally, we find evidence that firm size and belonging to the enterprise group positively impact small businesses’ general innovations. We conclude with practical implications for policymakers and firm managers in Visegrad economies on measures that could be adopted to develop and improve upon existing and new policy initiatives to increase the effect of major and minor innovation outcomes. Small businesses, Public procurement contracts, Major innovations, Minor innovations, Intellectual property rights, Utility models, Czech Republic.

Project description:BackgroundResponsible innovation in health (RIH) emphasizes the importance of developing technologies that are responsive to system-level challenges and support equitable and sustainable healthcare. To help decision-makers identify whether an innovation fulfills RIH requirements, we developed and validated an evidence-informed assessment tool comprised of 4 inclusion and exclusion criteria, 9 assessment attributes and a scoring system.MethodsWe conducted an inter-rater reliability assessment to establish the extent to which 2 raters agree when applying the RIH Tool to a diversified sample of health innovations (n=25). Following the Tool's 3-step process, sources of information were collected and cross-checked to ensure their clarity and relevance. Ratings were reported independently in a spreadsheet to generate the study's database. To measure inter-rater reliability, we used: a non-adjusted index (percent agreement), a chance-adjusted index (Gwet's AC) and the Pearson's correlation coefficient. Results of the Tool's application to the whole sample of innovations are summarized through descriptive statistics.ResultsOur findings show complete agreement for the screening criteria, "almost perfect" agreement for 7 assessment attributes, "substantial" agreement for 2 attributes and "almost perfect" agreement for the RIH overall score. A large portion of the sample obtained high scores for 6 attributes (health relevance, health inequalities, responsiveness, level and intensity of care and frugality) and low scores for 3 attributes (ethical, legal, and social issues [ELSIs], inclusiveness and eco-responsibility). At the rating step, 88% of the innovations had a sufficient number of attributes documented (≥ 7/9), but the assessment was based on sources of moderate to high quality (mean score ≥ 2 points) for 36% of the sample. While "Almost all RIH features" were present for 24% of the innovations (RIH mean score between 4.1-5.0 points), "Many RIH features" were present for 52% of the sample (3.1-4.0 points) and "Few RIH features" were present for 24% of the innovations (2.1-3.0 points).ConclusionBy confirming key aspects of the RIH Tool's reliability and applicability, our study brings its development to completion. It can be jointly put into action by innovation stakeholders who want to foster innovations with greater social, economic and environmental value.

Dataset Information

Buyers' role in innovation procurement: Evidence from US military R&D contracts.

Publications

Buyers' role in innovation procurement: Evidence from US military R&D contracts.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets